How much revenue does Bactiguard Holding AB (publ) make?

Bactiguard Holding AB (publ) reported 215.92 million SEK in revenue for fiscal year 2025, down 11.4% from 243.68 million SEK in fiscal year 2024. In Q2 2026 revenue was 54.00 million SEK.

What companies are similar to Bactiguard Holding AB (publ)?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Paxman AB (publ) (PAX.ST), Episurf Medical AB (publ) (EPIS-B.ST), C-Rad AB (publ) (CRAD-B.ST), FluoGuide A/S (FLUO.ST).

Bactiguard Holding AB (publ) (BACTI-B.ST) Stock

About Bactiguard Holding AB (publ)

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. The company also has a portfolio of wound management products, such as Hydrocyn Aqua, an antimicrobial solution and gel for acute, chronic, and infected wounds; and surgical sutures comprising non-absorbable, natural abso...

At a glance

Bactiguard Holding AB (publ) reported revenue of 215.92 million SEK for fiscal year 2025, down 11.4% from fiscal year 2024, and net income of -7.84 million SEK. In Q2 2026 (the quarter ended June 30, 2026) revenue was 54.00 million SEK, up 11.9% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.